Citations (414)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (48)
Liang Liu & Wenze Huang. (2023) hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression. Cancer Biology & Therapy 24:1.
Read now
Read now
Shuo Yang, Ping Zhou, Lelei Zhang, Xiangpeng Xie, Yuanyi Zhang, Kaida Bo, Jing Xue, Wei Zhang, Faxue Liao, Pengfei Xu, Yong Hu, Ruyu Yan, Dan Liu, Jun Chang & Kecheng Zhou. (2023) VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma. Cancer Biology & Therapy 24:1.
Read now
Read now
Rafaël Moisan, Xavier Leroy, Damien Fron, Pierre Leblond & Cyril Lervat. (2023) Uncommon metachronous multiple sites recurrences of metastatic osteosarcoma cured by surgery: a case report. Acta Oncologica 62:9, pages 1106-1109.
Read now
Read now
Jiefeng Zhang, YiXuan Tan, Yanwei Shou, Liangqin Fang, Xiaoming Li & Jin Lai. (2023) The relationship between adjuvant radiotherapy and survival of osteosarcoma: a case-control study. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-14.
Read now
Read now
Zhendong Li, Chenliang Zhou, Qing Peng, Suguo Wang, Guowei Qian, Lina Tang, Xin Zhou, Qingcheng Yang, Zan Shen, GaoZhong Huang, Yonggang Wang & Hongtao Li. (2022) Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma. Cancer Management and Research 14, pages 1671-1682.
Read now
Read now
Olivier Camuzard, Marie Nollet, Sabine Santucci-Darmanin, Marie-Charlotte Trojani, Nadia Ben Abderrahman, Virginie Virolle, Fanny Burel-Vandenbos, Sophie Pagnotta, François Orange, Ewa Kolano-Merlin, Georges F. Carle & Valérie Pierrefite-Carle. (2022) Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors. Autophagy Reports 1:1, pages 418-437.
Read now
Read now
Jinti Lin, Ankai Xu, Jiakang Jin, Man Zhang, Jianan Lou, Chao Qian, Jian Zhu, Yitian Wang, Zhengming Yang, Xiumao Li, Wei Yu, Bing Liu & Huimin Tao. (2022) MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. OncoImmunology 11:1.
Read now
Read now
Zhimin Yang, Tang Liu, Xiaolei Ren, Mei Yang, Chao Tu & Zhihong Li. (2022) Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks. Cell Cycle 21:20, pages 2121-2131.
Read now
Read now
Qiu Chen, Haisen Zhou & Weihao Rong. (2022) Circular RNA_0078767 upregulates Kruppel-like factor 9 expression by targeting microRNA-889, thereby inhibiting the progression of osteosarcoma. Bioengineered 13:6, pages 14313-14328.
Read now
Read now
Haofeng Liang, Lin Li, Shuang Zhu, Jianye Tan, Bingsheng Yang, Xiaoping Wang, Guofeng Wu, Chao Xie, Lutao Li, Zhengwei Liu, Yucong Li, Haoqiang Song, Guoli Chen & Lijun Lin. (2022) MicroRNA-744-5p suppresses tumorigenesis and metastasis of osteosarcoma through the p38 mitogen-activated protein kinases pathway by targeting transforming growth factor-beta 1. Bioengineered 13:5, pages 12309-12325.
Read now
Read now
Wei Wu, Linxiu Wang & Sen Li. (2022) Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis. Bioengineered 13:4, pages 9397-9410.
Read now
Read now
Hong-Jian Shan, Wen-Xiang Gu, Gang Duan & Hong-Liang Chen. (2022) Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression. Bioengineered 13:4, pages 8038-8050.
Read now
Read now
Dan Zhou & Ling He. (2022) Sauchinone inhibits hypoxia-induced invasion and epithelial–mesenchymal transition in osteosarcoma cells via inactivation of the sonic hedgehog pathway. Journal of Receptors and Signal Transduction 42:2, pages 173-179.
Read now
Read now
Guodong Liu, Honggang Mao, Yan Liu, Zun Zhang, Si Ha & Xiaoyan Zhang. (2022) miR-148b-3p, as a tumor suppressor, targets son of sevenless homolog 1 to regulate the malignant progression in human osteosarcoma. Bioengineered 13:2, pages 4271-4284.
Read now
Read now
Xinyue Ju, Yan Tang, Rongfeng Qu & Shuhong Hao. (2021) The Emerging Role of Circ-SHPRH in Cancer. OncoTargets and Therapy 14, pages 4177-4188.
Read now
Read now
Weijie Chen, Su Wu, Yang Huang, Tingting Zhang, Hao Dong, Xing Zheng, Tao Chen, Xiaokang Gong, Gang Liu & Xing Zhao. (2021) A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells. OncoTargets and Therapy 14, pages 4791-4804.
Read now
Read now
Haoran Wang, Zixiang Liu, Peng Wu, Hanqing Wang & Weiwei Ren. (2021) NUSAP1 Accelerates Osteosarcoma Cell Proliferation and Cell Cycle Progression via Upregulating CDC20 and Cyclin A2. OncoTargets and Therapy 14, pages 3443-3454.
Read now
Read now
Chang Liu, Xuesong Han, Bo Li, Shaobin Huang, Zhong Zhou, Zhiwei Wang & Wanming Wang. (2021) MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells. Cancer Management and Research 13, pages 6879-6889.
Read now
Read now
Jianjun Yuan, Yan Liu, Quan Zhang, Zhishuai Ren, Guang Li & Rong Tian. (2021) CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760. Cancer Management and Research 13, pages 4433-4445.
Read now
Read now
Xuantao Hu, Xia Chen, Tao Li, Zicheng Liu, Xiaoning Guo & Zhengxiao Ouyang. (2021) Effect of Cisplatin Arterial Infusion (CAI) on Primary Nonmetastatic Pelvic Osteosarcoma: A Preliminary Study. Cancer Management and Research 13, pages 1491-1503.
Read now
Read now
Cailong Zhang, Na Na, Li Liu & Yingzhu Qiu. (2021) CircRNA hsa_circ_0005909 Promotes Cell Proliferation of Osteosarcoma Cells by Targeting miR-338-3p/HMGA1 Axis. Cancer Management and Research 13, pages 795-803.
Read now
Read now
Aykut Özgür. (2021) Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells. Journal of Chemotherapy 33:8, pages 554-563.
Read now
Read now
Cristina Meazza & Sebastian Dorin Asaftei. (2021) State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma. Expert Opinion on Pharmacotherapy 22:15, pages 1995-2006.
Read now
Read now
Grace Nevil, Michael Roth, Jonathan Gill, Wendong Zhang, Beverly Teicher, Stephen W. Erickson, Gregory Gatto, Malcom Smith, E. Anders Kolb & Richard Gorlick. (2021) Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. Pediatric Hematology and Oncology 38:1, pages 8-13.
Read now
Read now
Cheng Cheng, Haoping Zhang, Zhipeng Dai & Jia Zheng. (2021) Circular RNA circVRK1 suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating zinc finger protein ZNF652 expression via microRNA miR-337-3p. Bioengineered 12:1, pages 5411-5427.
Read now
Read now
Xin Wang, Xiaojie Yu, Xiongwu Long & Qianqian Pu. (2021) MIR205 host gene (MIR205HG) drives osteosarcoma metastasis via regulating the microRNA 2114-3p (miR-2114-3p)/twist family bHLH transcription factor 2 (TWIST2) axis. Bioengineered 12:1, pages 1576-1586.
Read now
Read now
Jitian Li, Liping Dai, Manyu Huang, Yan Ma, Zhiping Guo, Xiao Wang, Wuyin Li & Jian-Ying Zhang. (2021) Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach. OncoImmunology 10:1.
Read now
Read now
Shuheng Liu & Xianghai Meng. (2020) LINC00662 Long Non-Coding RNA Knockdown Attenuates the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Regulating the microRNA-15a-5p/Notch2 Axis. OncoTargets and Therapy 13, pages 7517-7530.
Read now
Read now
Fei Huang, Faxue Liao, Guangwen Ma, Yong Hu, Chi Zhang, Pengfei Xu, Tangbing Xu & Jun Chang. (2020) TBRG4 Knockdown Suppresses Proliferation and Growth of Human Osteosarcoma Cell Lines MG63 Through PI3K/Akt Pathway. OncoTargets and Therapy 13, pages 7271-7281.
Read now
Read now
Yanran Huang, Jin Chen, Shengdong Yang, Tao Tan, Nan Wang, Yuping Wang, Lulu Zhang, Chunmei Yang, Huakun Huang, Jinyong Luo & Xiaoji Luo. (2020) Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways. Drug Design, Development and Therapy 14, pages 4625-4637.
Read now
Read now
Shengliang Sun, Lei Fu, Gen Wang, Jianli Wang & Liping Xu. (2020) MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3. Cancer Management and Research 12, pages 8159-8169.
Read now
Read now
Liyun Zheng, Shiji Fang, Junguo Hui, Vinothkumar Rajamanickam, Minjiang Chen, Qiaoyou Weng, Xulu Wu, Zhongwei Zhao & Jiansong Ji. (2020) Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction in Human Osteosarcoma Cells. Cancer Management and Research 12, pages 5919-5929.
Read now
Read now
Chaofan Xie, Guanzhao Liang, Yinfeng Xu & Erhu Lin. (2020) Circular RNA hsa_circ_0003496 Contributes to Tumorigenesis and Chemoresistance in Osteosarcoma Through Targeting (microRNA) miR-370/Krüppel-Like Factor 12 Axis. Cancer Management and Research 12, pages 8229-8240.
Read now
Read now
Bin Wang & Jingyu Li. (2020) Piceatannol Suppresses the Proliferation and Induced Apoptosis of Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway. Cancer Management and Research 12, pages 2631-2640.
Read now
Read now
Yu-Peng Liu, Jun Wan, Feng Long, Jian Tian & Can Zhang. (2020) circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma. Cancer Management and Research 12, pages 1229-1240.
Read now
Read now
Lei Wang, Ya Yang, Xiu-Mei Wang, Cheng-Qun Wang, Yuan-Min Zhang & Bing-Liang Li. (2020) MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway. Journal of Receptors and Signal Transduction 40:6, pages 584-590.
Read now
Read now
Gu Gong, Zhifeng Han, Wenjun Wang, Qinli Xu & Jingzhe Zhang. (2020) Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375. Cell Cycle 19:17, pages 2139-2147.
Read now
Read now
Qiang Zhou, Tongzhou Hu & Yuan Xu. (2020) Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling. Journal of Drug Targeting 28:2, pages 204-211.
Read now
Read now
Renna Qiu, Denghua Sun, Yuzhuo Bai, Jiannan Li & Lizhe Wang. (2020) Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma. Drug Delivery 27:1, pages 1704-1717.
Read now
Read now
Yongshuang Li, Hao Hou, Peng Zhang & Zhiyu Zhang. (2020) Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Drug Delivery 27:1, pages 1044-1053.
Read now
Read now
Yuying Zhang, Qianqian Zhang, Jie Bao, Jintian Huang & Hua Zhang. (2019) Apiosporamide, A 4-hydroxy-2-pyridone Alkaloid, Induces Apoptosis Via PI3K/Akt Signaling Pathway In Osteosarcoma Cells. OncoTargets and Therapy 12, pages 8611-8620.
Read now
Read now
Gang Zhao, Liwei Zhang, Dejian Qian, Yifeng Sun & Wei Liu. (2019) miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3. OncoTargets and Therapy 12, pages 6133-6143.
Read now
Read now
Meixian Chen, Lisheng Zhou, Zhaoxia Liao, Xijiu Ye, Xujun Xuan, Beibei Gu & Fuding Lu. (2019) Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis. Cancer Management and Research 11, pages 9505-9515.
Read now
Read now
Daliang Kong, Boda Ying, Jinrui Zhang & Hongliang Ying. (2019) RETRACTED ARTICLE: The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3913-3919.
Read now
Read now
Yongkun Wang, Baozhen Sun, Qiao Zhang, Hang Dong & Jingzhe Zhang. (2019) p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2891-2899.
Read now
Read now
Zhengqi Bao, Xiusong Dai, Peter Wang, Yisheng Tao & Damin Chai. (2019) Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways. Cell Cycle 18:12, pages 1379-1392.
Read now
Read now
Claudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, Federica Magagnoli, Piero Picci & Massimo Serra. (2019) Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment. Expert Opinion on Drug Metabolism & Toxicology 15:4, pages 299-311.
Read now
Read now
Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, Silvia Luppi, Federica Magagnoli, Piero Picci & Massimo Serra. (2018) Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?. Expert Review of Molecular Diagnostics 18:11, pages 947-961.
Read now
Read now
Articles from other publishers (366)
Feifei Pu, Haoyu Guo, Deyao Shi, Fengxia Chen, Yizhong Peng, Xin Huang, Jianxiang Liu, Zhicai Zhang & Zengwu Shao. (2024) The generation and use of animal models of osteosarcoma in cancer research. Genes & Diseases 11:2, pages 664-674.
Crossref
Crossref
Gerbenn Seraphin, Sandra Rieger, Martin Hewison, Enrico Capobianco & Thomas S. Lisse. (2023) The impact of vitamin D on cancer: A mini review. The Journal of Steroid Biochemistry and Molecular Biology 231, pages 106308.
Crossref
Crossref
Wen Tian, Xiaoying Niu, Feifei Feng, Xin Wang, Jiaqiang Wang, Weitao Yao & Peng Zhang. (2023) The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy. Biomedicine & Pharmacotherapy 163, pages 114771.
Crossref
Crossref
Dawei Wang, Yang Wang, Huadong Wang, Yafeng Yang, Li Li, Yihao Liu & Xin Yin. (2023)
Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering
miR
‐194‐5p and elevating
HK2
expression
. Clinical and Experimental Pharmacology and Physiology 50:6, pages 463-475.
Crossref
Crossref
Shouchao Hu & Wenzhi Wang. (2022) ARHGAP44 expression is associated with the metastasis of osteosarcoma and is a promising prognostic biomarker. Journal of Orthopaedic Research 41:6, pages 1348-1355.
Crossref
Crossref
Zhi-qiang Wei, Sheng Ding & Yan-cai Yang. (2023) TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics. Frontiers in Oncology 13.
Crossref
Crossref
Jin Zeng, Yi Peng, Dong Wang, Khan Ayesha & Shijie Chen. (2023) The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Qiuping Lu, Huakun Huang, Xiaoxuan Wang, Lijuan Luo, Haichao Xia, Lulu Zhang, Jingtao Xu, Yanran Huang, Xiaoji Luo & Jinyong Luo. (2023) Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways. Pharmacological Research 191, pages 106760.
Crossref
Crossref
Keke He, Yue Qin, Fangfang Gou & Jia Wu. (2023) A Novel Medical Decision-Making System Based on Multi-Scale Feature Enhancement for Small Samples. Mathematics 11:9, pages 2116.
Crossref
Crossref
Zhaoyu Wang, Peng Yu, Yutong Zou, Jieyi Ma, Hui Han, Wei Wei, Chunlong Yang, Siyi Zheng, Siyao Guo, Juan Wang, Lianlian Liu & Shuibin Lin. (2023) METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene.
Crossref
Crossref
Zhibing Dai, Yachao Sun, Maierdanjiang Maihemuti & Renbing Jiang. (2023) Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients. Frontiers in Genetics 14.
Crossref
Crossref
Zheng Lian, Yunheng Tai, Huanling Xia & Honglin Zhai. (2023) QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA. Anti-Cancer Agents in Medicinal Chemistry 23:6, pages 726-733.
Crossref
Crossref
Lei Tang, Fu Cegang, Hongwei Zhao, Bofei Wang, Siyu Jia, Haidan Chen & Huili Cai. (2023) Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma
Growth with Induction of IFN-γ Secretion and Proliferation of
CD8+ T Cells. Current Cancer Drug Targets 23:4, pages 265-277.
Crossref
Crossref
Xuhui Yuan, Cong Ma, Jiayu Li, Junhong Li, Ronghui Yu, Feng Cai, Gaoyang Qu, Bo Yu, Lang Liu, Duo Zeng, QuanHui Jiao, Qi Liao & Xiaobin Lv. (2023) Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS. Journal of Bone Oncology 39, pages 100472.
Crossref
Crossref
Xiaonan Zhang, Hao Wei, Chao Dong, Jian Wang, Tao Zhang, Lifei Huang, Dong Ni & Yongxiang Luo. (2023) 3D printed hydrogel/bioceramics core/shell scaffold with NIR-II triggered drug release for chemo-photothermal therapy of bone tumors and enhanced bone repair. Chemical Engineering Journal 461, pages 141855.
Crossref
Crossref
Jing Li, Chenguang Zhao, Dong Wang, Shuang Wang, Hui Dong, Difan Wang, Yubing Yang, Jiaxi Li, Feng Cui, Xijing He & Jie Qin. (2022) ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth. Cancer Immunology, Immunotherapy 72:4, pages 903-916.
Crossref
Crossref
Zhuce Shao, JiaChen Li, Ze Liu & Shuxiong Bi. (2023) Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study. Cancer Medicine 12:8, pages 9589-9603.
Crossref
Crossref
Shengwen Cheng, Senrui Liu, Bowen Chen, Chengcheng Du, Pengcheng Xiao, Xuefeng Luo, Li Wei, Yiting Lei, Chen Zhao & Wei Huang. (2023) Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways. Chinese Medicine 18:1.
Crossref
Crossref
Yiping Weng, Weihao Duan, Xuecheng Yu, Furen Wu, Daibin Yang, Yuqing Jiang, Jingbin Wu, Muyi Wang, Xin Wang, Yifei Shen, Yunkun Zhang & Hua Xu. (2023)
MicroRNA
‐324‐3p inhibits osteosarcoma progression by suppressing
PGAM1
‐mediated aerobic glycolysis
. Cancer Science.
Crossref
Crossref
Zhen Geng, Xiaoxiang Ren & Sicheng Wang. 2023. Biomaterials Effect on the Bone Microenvironment. Biomaterials Effect on the Bone Microenvironment
157
173
.
Zhe Li, Chi Jin, Xinchang Lu, Yan Zhang, Yi Zhang, Jia Wen, Yongkui Liu, Xiaoting Liu & Jiazhen Li. (2023) Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single‐cell data. The Journal of Gene Medicine.
Crossref
Crossref
Yubin Qi, Lin Yao, Jianke Liu & Wen Wang. (2023) Piperine improves the sensitivity of osteosarcoma cells to doxorubicin by inducing apoptosis and inhibiting the PI3K/AKT/GSK-3β pathway. Journal of Orthopaedic Surgery and Research 18:1.
Crossref
Crossref
Chengyu Hu. (2023) LncRNA DSCAM-AS1: A Pivotal Therapeutic Target in Cancer. Mini-Reviews in Medicinal Chemistry 23:5, pages 530-536.
Crossref
Crossref
Lin Shen, Han Li, Ronghan Liu, Chendan Zhou, Morgan Bretches, Xuan Gong, Laitong Lu, Ying Zhang, Kai Zhao, Bin Ning, Shang‐You Yang & Aijun Zhang. (2022)
DEPDC1
as a crucial factor in the progression of human osteosarcoma
. Cancer Medicine 12:5, pages 5798-5808.
Crossref
Crossref
Hailong Tian, Jiangjun Cao, Bowen Li, Edouard C. Nice, Haijiao Mao, Yi Zhang & Canhua Huang. (2023) Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Research 11:1.
Crossref
Crossref
Yang Liu, Zhongyu Jiang, Shizheng Tong, Yifu Sun, Yu Zhang, Jiayuan Zhang, Duoyi Zhao, Yuanzhen Su, Jianxun Ding & Xuesi Chen. (2023) Acidity‐Triggered Transformable Polypeptide Self‐Assembly to Initiate Tumor‐Specific Biomineralization. Advanced Materials, pages 2203291.
Crossref
Crossref
Longhai Du, Guanghao Zhu, Yanlong Xu, Binxu Han, Yu Wang, Minhui Zhu, Yingdi Meng, Huaiwen Chen & Zuochong Yu. (2023) Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Yu Chen, Wei Yan, Hongqing Wang, Zhiliang Ou, Huihong Chen, Zhenhua Huang, Jinlian Yang, Biqiong Liu, Fanjie Ou & Huang Zhang. (2023) The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma. Mediators of Inflammation 2023, pages 1-11.
Crossref
Crossref
Xin Wu, Shiwei Ma, Zhongguang Wu & Qiangqiang Zhao. (2023) Global scientific trends on matrix metalloproteinase and osteosarcoma: A bibliometric and visualized analysis. Frontiers in Oncology 13.
Crossref
Crossref
Wei Zhong, Wei Luo, Zili Lin, Ziyi Wu, Yuhao Yuan & Yizhe He. (2023) Prognostic analysis of telangiectatic osteosarcoma of the extremities. Frontiers in Oncology 12.
Crossref
Crossref
Haichao Xia, Yanran Huang, Lulu Zhang, Lijuan Luo, Xiaoxuan Wang, Qiuping Lu, Jingtao Xu, Chunmei Yang, Habu Jiwa, Shiqiong Liang, Liping Xie, Xiaoji Luo & Jinyong Luo. (2023) Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride. Cancers 15:3, pages 961.
Crossref
Crossref
Xueli Zhou, Panpan Wei, Xinju Wang, Jianguo Zhang & Yulin Shi. (2023) miR-141-3p Promotes the Cisplatin Sensitivity of Osteosarcoma
Cell through Targeting the Glutaminase [GLS]-Mediated Glutamine
Metabolism. Current Molecular Medicine 23:2, pages 177-184.
Crossref
Crossref
Kui Chen, Ruyi Zhou, Haojun Liang, You Liao, Shuang Zhu, Xinghua Dong, Yujiao Wang, Sen Liu, Fan Hu, Hao Li, Qiuyang Liu, Linwen Lv, Ya-nan Chang, Juan Li, Gengmei Xing & Zhanjun Gu. (2023) Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement. Nano Today 48, pages 101739.
Crossref
Crossref
Julia Karska, Szymon Kowalski, Jolanta Saczko, Mihaela G. Moisescu & Julita Kulbacka. (2023) Mechanosensitive Ion Channels and Their Role in Cancer Cells. Membranes 13:2, pages 167.
Crossref
Crossref
Liyuan Tang & Binbin Liu. (2023) Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival. Medicine 102:4, pages e32692.
Crossref
Crossref
Hendrik Setia Budi, Laith A. Younus, Methaq Hadi Lafta, Sameena Parveen, Hawraa Jabbar Mohammad, Zahraa Haleem Al-qaim, Mohammed Abed Jawad, Rosario Mireya Romero Parra, Yasser Fakri Mustafa, Firas Rahi Alhachami, Sajad Karampoor & Rasoul Mirzaei. (2023) The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Hanqing Li, Yang Li, Lei Song, Qiuchi Ai & Shuai Zhang. (2023) Retrospective review of safety and efficacy of anlotinib in advanced osteosarcoma with metastases after failure of standard multimodal therapy. Asia-Pacific Journal of Clinical Oncology.
Crossref
Crossref
Yixin Liu, Wenyan She, Yi Li, Miao Wang, Yin Liu, Biao Ning, Tianzi Xu, Tianhe Huang & Yongchang Wei. (2023) Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1. Journal of Translational Medicine 21:1.
Crossref
Crossref
Kelly Rock, Odessa Addison, Vicki L. Gray, Robert M. Henshaw, Christopher Ward & Victoria Marchese. (2023) Skeletal Muscle Measurements in Pediatric Hematology and Oncology: Essential Components to a Comprehensive Assessment. Children 10:1, pages 114.
Crossref
Crossref
Ravikanth Reddy. (2023) Secondary osteosarcoma of the femur following radiotherapy for ewing's sarcoma. Journal of Microscopy and Ultrastructure 0:0, pages 0.
Crossref
Crossref
Jun Wang, Mingzhi Gong, Zhenggang Xiong, Yangyang Zhao & Deguo Xing. (2023) ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells
and Predicts Prognosis in Osteosarcoma. Combinatorial Chemistry & High Throughput Screening 26:1, pages 135-148.
Crossref
Crossref
Enhui Li, Shoubin Zhong, Guikai Ma, Qian Wang & Yanfang Gao. (2023) MIR503HG Overexpression Inhibits the Malignant Behaviors of Osteosarcoma Cells by Sponging miR-103a-3p. Critical Reviews in Eukaryotic Gene Expression 33:3, pages 1-11.
Crossref
Crossref
Xiaoling Huang, Wei Wang & Yong Li. (2023) Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma. Genetics and Molecular Biology 46:1.
Crossref
Crossref
Guilherme S. Medeiros, Luis F.M. Oliveira, Filipe V. Ferreira, Lucas P. Souza, Richard A. Martin, Ivone R. de Oliveira & João H. Lopes. (2023) A perfect pair: Niobium- and gallium-doped ceramic biomaterial enabled by coupled synthesis method with potential application for bone regeneration and cancer-targeted therapy. Journal of Non-Crystalline Solids 599, pages 121962.
Crossref
Crossref
H. Xu, H. Zheng, Q. Zhang, H. Song, Q. Wang, J. Xiao, Y. Dong, Z. Shen, S. Wang, S. Wu, Y. Wei, W. Lu, Y. Zhu & X. Niu. (2023) A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts. Clinical Oncology 35:1, pages e48-e59.
Crossref
Crossref
Huanhuan Lv, Jiancheng Yang & Yanru Xue. 2023. Biological Effects of Static Magnetic Fields. Biological Effects of Static Magnetic Fields
321
336
.
Agnes L. Sorteberg, Linnea Ek, Ingrid Lilienthal & Nikolas Herold. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
39
.
Douglas Harrison, Jonathan Gill, Michael Roth, Pooja Hingorani, Wendong Zhang, Beverly Teicher, Eric Earley, Stephen Erickson, Gregory Gatto, Raushan Kurmasheva, Peter Houghton, Malcolm Smith, E. Anders Kolb & Richard Gorlick. (2022) Evaluation of the pan‐class I phosphoinositide 3‐kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatric Blood & Cancer 70:1.
Crossref
Crossref
Goran J. Djuričić, Helmut Ahammer, Stanislav Rajković, Jelena Djokić Kovač, Zorica Milošević, Jelena P. Sopta & Marko Radulovic. (2022) Directionally Sensitive Fractal Radiomics Compatible With Irregularly Shaped Magnetic Resonance Tumor Regions of Interest: Association With Osteosarcoma Chemoresistance. Journal of Magnetic Resonance Imaging 57:1, pages 248-258.
Crossref
Crossref
Yue Luo, Bo Yang, Xiaopin Yuan & Jian Zheng. (2023)
Silencing
circUSP48
suppresses osteosarcoma progression by regulating the
miR
‐335/ smad nuclear interacting protein 1 pathway
. Journal of Clinical Laboratory Analysis 37:2.
Crossref
Crossref
Valentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi & Stefan E. G. Burdach. (2022) Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma. Cancers 15:1, pages 272.
Crossref
Crossref
Weifeng Tang, Yu Zhang, Haixia Zhang & Yan Zhang. (2022) Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells. Cancers 14:24, pages 6201.
Crossref
Crossref
Peijun Zhu, Ting Li, Qingqing Li, Yawen Gu, Yuan Shu, Kaibo Hu, Leifeng Chen, Xiaogang Peng, Jie Peng & Liang Hao. (2022) Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma. Biomolecules 12:12, pages 1882.
Crossref
Crossref
Zhongyue Liu, Binfeng Liu, Chengyao Feng, Chenbei Li, Hua Wang, Haixia Zhang, Ping Liu, Zhihong Li, Shasha He & Chao Tu. (2022) Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma. Frontiers in Immunology 13.
Crossref
Crossref
Yanjiao Wu, Zhiyun Wang, Jianlin Shen, Wei Yan, Shurong Xiang, Huan Liu & Wenhua Huang. (2022) The role of m6A methylation in osteosarcoma biological processes and its potential clinical value. Human Genomics 16:1.
Crossref
Crossref
Ziyan Zhang, Lin Zhou, Shicheng Zhou & Xin Li. (2022) Circular RNA hsa_circ_0069117 suppresses proliferation and migration of osteosarcoma cells lines via miR-875-3p/PF4V1 axis. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Crossref
Pengfei Zan, Hongsheng Wang, Zhengdong Cai, Jiakang Shen & Wei Sun. (2022) Revision surgeries for tumor endoprostheses around the knee joint: a mid-long-term follow-up of 20 cases. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Federica Giordano, Stefania Lenna, Gherardo Baudo, Riccardo Rampado, Matteo Massaro, Enrica De Rosa, April Ewing, Lyazat Kurenbekova, Marco Agostini, Jason T. Yustein & Francesca Taraballi. (2022) Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma. Cancer Nanotechnology 13:1.
Crossref
Crossref
Shaohua Cheng, Xinghan Huang & Weichun Guo. (2022) TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway. Journal of Bone Oncology 37, pages 100461.
Crossref
Crossref
Sara F.F. Almeida, Alexandra Fonseca, José Sereno, Hugo R. S. Ferreira, Mariana Lapo‐Pais, Tânia Martins‐Marques, Teresa Rodrigues, Rui C. Oliveira, Catarina Miranda, Luís P. Almeida, Henrique Girão, Amílcar Falcão, Antero J. Abrunhosa & Célia M. Gomes. (2022) Osteosarcoma‐Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis. Small 18:49.
Crossref
Crossref
Minghua Li & Chun Liang. (2022) LncDC: a machine learning-based tool for long non-coding RNA detection from RNA-Seq data. Scientific Reports 12:1.
Crossref
Crossref
Siying Qin, Xueying Wang, Pan Han, Zhiping Lai, Yingying Ren, Rui Ma, Cheng Cheng, Ting Wang & Ying Xu. (2022) LRP1-Mediated Endocytosis May Be the Main Reason for the Difference in Cytotoxicity of Curcin and Curcin C on U2OS Osteosarcoma Cells. Toxins 14:11, pages 771.
Crossref
Crossref
Kai Zheng, Xiu-chun Yu, Ming Xu & Jing-ming Wang. (2022) Conservative surgery with microwave ablation for recurrent bone tumor in the extremities: a single-center study. BMC Cancer 22:1.
Crossref
Crossref
Mohamed A Abdelgawad, Della G T Parambi, Mohammed M. Ghoneim, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea, Ahmed HM Hassan & Mohamed E.A. Abdelrahim. (2022) A meta‐analysis comparing efficiency of limb‐salvage surgery vs amputation on patients with osteosarcoma treated with neoadjuvant chemotherapy. International Wound Journal 19:7, pages 1616-1624.
Crossref
Crossref
Yingli Fu, Jing Yu, Ioanna Liatsou, Yong Du, Anders Josefsson, Jessie R. Nedrow, Hans Rindt, Jeffrey N. Bryan, Dara L. Kraitchman & George Sgouros. (2022) Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma. European Journal of Nuclear Medicine and Molecular Imaging 49:13, pages 4382-4393.
Crossref
Crossref
Haiyan Qiu, Di Yang, Xiaolin Li & Fabo Feng. (2022) LncRNA CASC9 promotes cell proliferation and invasion in osteosarcoma through targeting miR-874-3p/SOX12 axis. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Crossref
Yujian Zhong, Yubiao Zhang, Sixing Wei, Junwen Chen, Changheng Zhong, Wenxiang Cai, Wenyi Jin & Hao Peng. (2022) Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature. Frontiers in Endocrinology 13.
Crossref
Crossref
Natalia Todosenko, Kristina Yurova, Olga Khaziakhmatova, Vladimir Malashchenko, Igor Khlusov & Larisa Litvinova. (2022) Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. Pharmaceutics 14:10, pages 2181.
Crossref
Crossref
Shunhan Yao, Meiling Deng, Xiaojing Du, Qingfeng Chen & Rongzhi Huang. (2022) Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma. Journal of Immunology Research 2022, pages 1-12.
Crossref
Crossref
Claudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio, Silvia Luppi, Leonardo Fantoni, Katia Scotlandi, Toni Ibrahim & Massimo Serra. (2022) Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing. International Journal of Molecular Sciences 23:19, pages 11787.
Crossref
Crossref
Xiuxin Han, Yan Zhang, Feng Lu, Jinyan Feng, Chao Zhang & Guowen Wang. (2022) Hypermethylated PODN represses the progression of osteosarcoma by inactivating the TGF-β/Smad2/3 pathway. Pathology - Research and Practice 238, pages 154075.
Crossref
Crossref
Jingtao Xu, Xiaoxuan Wang, Lijuan Luo, Haichao Xia, Qiuping Lu, Yanran Huang, Yuping Wang, Jun Zhang, Habu Jiwa, Runhan Zhao, Chuang Xiong, Jinyong Luo & Xiaoji Luo. (2022) Neferine inhibits the growth of human osteosarcoma cells through activating P38/JNK and suppressing Wnt/β-catenin signaling pathway. Journal of Functional Foods 97, pages 105262.
Crossref
Crossref
Xiucai Ma, Zhigang Suo, Xiaoyan Ma, Chunrui Zhan, Guodong Luo & Jianmin Song. (2022) Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma. Journal of Ethnopharmacology 296, pages 115433.
Crossref
Crossref
Yong Cui & Yong-Yong Dong. (2022) ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway. Aging 14:18, pages 7505-7516.
Crossref
Crossref
Caihong Ye, Mengqi Wei, Huakun Huang, Yuping Wang, Lulu Zhang, Chunmei Yang, Yanran Huang & Jinyong Luo. (2022) Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways. Biological Chemistry 403:10, pages 929-943.
Crossref
Crossref
Ting-Yi Sun, Chun-Liang Hsu, Meei-Shyuan Lee, Tsu-Te Yeh, Hou-Chuan Lai, Ke-Li Wu, Zhi-Fu Wu & Wei-Cheng Tseng. (2022) Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in limb-salvage surgery for osteosarcoma: A retrospective analysis. Medicine 101:38, pages e30840.
Crossref
Crossref
Jia Guo, Weikai Sun, Cheng Dong, Zengjie Wu, Xiaoli Li, Ruizhi Zhou & Wenjian Xu. (2022) Intravoxel incoherent motion imaging combined with diffusion kurtosis imaging to assess the response to radiotherapy in a rabbit VX2 malignant bone tumor model. Cancer Imaging 22:1.
Crossref
Crossref
Binfeng Liu, Chengyao Feng, Zhongyue Liu, Chao Tu & Zhihong Li. (2022) A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity. Frontiers in Pharmacology 13.
Crossref
Crossref
Nan Wei, Gong Chao-yang, Zhou Wen-ming, Lei Ze-yuan, Shi Yong-qiang, Zhang Shun-bai, Zhang Kai, Ma Yan-chao & Zhang Hai-hong. (2022) A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma. Frontiers in Pharmacology 13.
Crossref
Crossref
Dong Hu, Yongbin Zheng, Xuehai Ou, Lijun Zhang, Xiaolong Du & Shaoyan Shi. (2022) Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma. Frontiers in Oncology 12.
Crossref
Crossref
Zhe Yang, Zuhao Li, Yue Zhao, Yueqi Zhao, Xingchen Li, Liang He, Andrei V. Zvyagin, Bai Yang, Quan Lin & Xiaojun Ma. (2022) Lotus Seedpod-Inspired Crosslinking-Assembled Hydrogels Based on Gold Nanoclusters for Synergistic Osteosarcoma Multimode Imaging and Therapy. ACS Applied Materials & Interfaces 14:30, pages 34377-34387.
Crossref
Crossref
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi & Bahman Yousefi. (2022) Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma. Current Medicinal Chemistry 29:25, pages 4436-4444.
Crossref
Crossref
Chunshan Jiang, Zhe Jiang & Xuewu Zhang. (2022) Circular RNA circMRPS35 regulates progression and autophagy in osteosarcoma cells by recruiting KAT6B to govern FOXO3. Anti-Cancer Drugs 33:7, pages 607-613.
Crossref
Crossref
Hongtao He, Muliang Ding, Tao Li, Wenzhi Zhao, Lu Zhang, Peng Yin & Wei Zhang. (2022) Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p. Laboratory Investigation 102:8, pages 826-837.
Crossref
Crossref
Shenghang Wang, Ting Huyan, Chenge Lou, Peng Shang & Hao Zhang. (2022) 12 T high static magnetic field suppresses osteosarcoma cells proliferation by regulating intracellular ROS and iron status. Experimental Cell Research 417:2, pages 113223.
Crossref
Crossref
Tongchun Li, Guangjie Xing, Liangliang Lu, Xiangzhen Kong & Jinwei Guo. (2022) CircAGFG1 Promotes Osteosarcoma Progression and Stemness by Competing with miR-302a-3p to Upregulate the Expression of LATS2. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-12.
Crossref
Crossref
Weiping Yao, Shuang Li, Ruiqi Liu, Mingyun Jiang, Liang Gao, Yanwei Lu, Xiaodong Liang & Haibo Zhang. (2022) Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer. Frontiers in Oncology 12.
Crossref
Crossref
Chun qian Zhang, Shuai Yang, Li jing Zhang, Jian nan Ma & De qiang Chen. (2022) A Cohort Study to Evaluate the Efficacy and Value of CT Perfusion Imaging in Patients with Metastatic Osteosarcoma after Chemotherapy. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Crossref
Lina Dai, Shimei Li, Xi Li & Bo Jiang. (2022) Propofol inhibits the malignant development of osteosarcoma U2OS cells via AMPK/FΟΧO1‑mediated autophagy. Oncology Letters 24:3.
Crossref
Crossref
Jie C. Nguyen, Soroush Baghdadi, Jennifer Pogoriler, Andressa Guariento, Chamith S. RajapakseAlexandre Arkader. (2022) Pediatric Osteosarcoma: Correlation of Imaging Findings with Histopathologic Features, Treatment, and Outcome. RadioGraphics 42:4, pages 1196-1213.
Crossref
Crossref
Foroogh Hosseini, Dariush Shanehbandi, Jafar Soleimanpour, Bahman Yousefi & Forough Alemi. (2022) Melatonin Increases the Sensitivity of Osteosarcoma Cells to
Chemotherapy Drug Cisplatin. Drug Research 72:06, pages 312-318.
Crossref
Crossref
Wei Liu, Yuechao Zhao, Guangfu Wang, Shuang Feng, Xuhui Ge, Wu Ye, Zhuanghui Wang, Yufeng Zhu, Weihua Cai, Jianling Bai & Xuhui Zhou. (2022) TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling. Redox Biology 53, pages 102344.
Crossref
Crossref
Yamato Ogiwara, Makoto Nakagawa, Fumihiko Nakatani, Yasushi Uemura, Rong Zhang & Chie Kudo-Saito. (2022) Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma. Cancer Letters 537, pages 215690.
Crossref
Crossref
Shigao Cheng & Wanchun Wang. (2022) Analysis of the subcellular location of FAM230B and its interaction with premature miR-302b in osteosarcoma. Journal of Bone and Mineral Metabolism 40:4, pages 554-560.
Crossref
Crossref
Jinjiong Hong, Qun Li, Xiaofeng Wang, Jie Li, Wenquan Ding, Haoliang Hu & Lingfeng He. (2022) Development and validation of apoptosis‐related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients. Journal of Clinical Laboratory Analysis 36:7.
Crossref
Crossref
Haixiao Wu, Guijun Xu, Zhijun Li, Yao Xu, Yile Lin, Vladimir P. Chekhonin, Karl Peltzer, Jun Wang, Shu Li, Huiyang Li, Jin Zhang, Yuan Xue, Wenjuan Ma, Xin Wang & Chao Zhang. (2022) Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy. Aging 14:12, pages 5023-5033.
Crossref
Crossref
Bangmin Wang, Xin Wang, Po Li, Xiaoying Niu, Xiaoxiao Liang, Guancong Liu, Zhiyong Liu & Hong Ge. (2022) Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma. Frontiers in Oncology 12.
Crossref
Crossref
Qi Liu & Feng Lin. (2022) Lentivirus‑induced knockdown of IARS2 expression inhibits the proliferation and promotes the apoptosis of human osteosarcoma cells. Oncology Letters 24:2.
Crossref
Crossref
Tianyi Zhu, Jing Han, Liu Yang, Zhengdong Cai, Wei Sun, Yingqi Hua & Jing Xu. (2022) Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications. Frontiers in Immunology 13.
Crossref
Crossref
Romilton dos Santos Amaral, José Araújo dos Santos Júnior, Zahily Herrero Fernández, Niége Maria de Paiva Melo, Arykerne Nascimento Casado da Silva, Josineide Marques do Nascimento Santos, Mariana Brayner Cavalcanti Freire Bezerra, Filipe Lopes de Barros Correia, Alberto Antônio da Silva, Alexandro Vasconcelos Alves & Luis Rodrigo D'Andrada Bezerra. (2022) Risk survey for the population of Recife and neighboring cities due to the occurrence of radium in groundwater. Journal of Environmental Radioactivity 247, pages 106868.
Crossref
Crossref
Guofeng Zhang, Yonglin Zhu, Chengzhen Jin, Qingpeng Shi, Xiaochun An, Licheng Song, Fengguang Gao & Shanhui Li. (2022) CircRNA_0078767 promotes osteosarcoma progression by increasing CDK14 expression through sponging microRNA-330-3p. Chemico-Biological Interactions 360, pages 109903.
Crossref
Crossref
Stephanie Villeneuve & Catherine Aftandilian. (2022) Neutropenia and Infection Prophylaxis in Childhood Cancer. Current Oncology Reports 24:6, pages 671-686.
Crossref
Crossref
Ivana Sirangelo, Maria Liccardo & Clara Iannuzzi. (2022) Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes. Antioxidants 11:6, pages 1087.
Crossref
Crossref
Yuxiang Kang, Guowang Li, Guohua Wang, Zhenxin Huo, Xiangling Feng, Lilong Du, Yongjin Li, Qiang Yang, Xinlong Ma, Bingbing Yu & Baoshan Xu. (2022) Development of a Risk Score Model for Osteosarcoma Based on DNA Methylation-Driven Differentially Expressed Genes. Journal of Oncology 2022, pages 1-9.
Crossref
Crossref
Wangrui Jin, Tao Zhang, Wenbo Zhou, Peng He, Yue Sun, Shijia Hu, Huang Chen, Xinglong Ma, Yangrui Peng, Zhengfang Yi, Mingyao Liu & Yihua Chen. (2022) Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis. Journal of Medicinal Chemistry 65:9, pages 6710-6728.
Crossref
Crossref
Jessica Beck, Ling Ren, Shan Huang, Erika Berger, Kathleen Bardales, Joshua Mannheimer, Christina Mazcko & Amy LeBlanc. (2022) Canine and murine models of osteosarcoma. Veterinary Pathology 59:3, pages 399-414.
Crossref
Crossref
Juncheng Cui, Dylan Dean, Francis J Hornicek, Guoliang Yi & Zhenfeng Duan. (2022)
Expression and Clinical Significance of High‐Mobility Group
AT‐hook 2
(
HMGA2
) in Osteosarcoma
. Orthopaedic Surgery 14:5, pages 955-966.
Crossref
Crossref
Ya-Hui Han, Chen-Guang Liu, Biao-Qi Chen, Chao-Ping Fu, Ranjith Kumar Kankala, Shi-Bin Wang & Ai-Zheng Chen. (2022) Orchestrated tumor apoptosis (Cu2+) and bone tissue calcification (Ca2+) by hierarchical Copper/Calcium-ensembled bioactive silica for osteosarcoma therapy. Chemical Engineering Journal 435, pages 134820.
Crossref
Crossref
Erika L. Cyphert, Nithya Kanagasegar, Ningjing Zhang, Greg D. Learn & Horst A. von Recum. (2022) PMMA Bone Cement Composite Functions as an Adjuvant Chemotherapeutic Platform for Localized and Multi‐Window Release during Bone Reconstruction. Macromolecular Bioscience 22:5, pages 2100415.
Crossref
Crossref
Forough Alemi, Faezeh Malakoti, Mostafa Vaghari‐Tabari, Jafar Soleimanpour, Nazila Shabestani, Aydin R. Sadigh, Nafiseh Khelghati, Zatollah Asemi, Yasin Ahmadi & Bahman Yousefi. (2022) DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma. Journal of Cellular Physiology 237:5, pages 2374-2386.
Crossref
Crossref
Ribin Fu & Xiaofang Hong. (2022) Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment. BioMed Research International 2022, pages 1-13.
Crossref
Crossref
Peng Luo, Jiarui Fang, Houqing Chen, Feng He, Siying Xiao, He Liu, Shizhuang Zhu, Jianzhou Luo & Changqing Jiang. (2022) c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1. Scientific Reports 12:1.
Crossref
Crossref
Gang Zhao, Jianxiao Liang, Jingjing Cao, Shanyong Jiang, Jianshu Lu & Baoen Jiang. (2022) Abnormal Function of Circulating Follicular Helper T Cells Leads to Different Manifestations of B Cell Maturation and Differentiation in Patients with Osteosarcoma. Journal of Healthcare Engineering 2022, pages 1-9.
Crossref
Crossref
Li-Yan Liang & Gui-Shi Li. (2022) The Roles of KIFC1 in the Development of Osteosarcoma: Characterization of Potential Therapeutic Targets. Computational and Mathematical Methods in Medicine 2022, pages 1-10.
Crossref
Crossref
Nicola Contessi Negrini, Claudio Ricci, Federica Bongiorni, Luisa Trombi, Delfo D’Alessandro, Serena Danti & Silvia Farè. (2022) An Osteosarcoma Model by 3D Printed Polyurethane Scaffold and In Vitro Generated Bone Extracellular Matrix. Cancers 14:8, pages 2003.
Crossref
Crossref
Xiaojing Chen, Lu Liu, Peng Liu, Yingying Chen, Dan Lin, Hao Yan, Qi Yan, Yi Wang, Yinda Qiu, Bo Fang, Huijing Huang, Jianchang Qian, Yunjie Zhao, Zhou Du, Qianwen Zhang, Xiaokun Li, Xiaohui Zheng & Zhiguo Liu. (2022) Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma. Journal of Medicinal Chemistry 65:7, pages 5374-5391.
Crossref
Crossref
Zheng Zhao, Shilu Chen, Yao Xiao, Maobin Xie & Wen Yu. (2022) Supercritical Fluid-Assisted Fabrication of PDA-Coated Poly (l-lactic Acid)/Curcumin Microparticles for Chemo-Photothermal Therapy of Osteosarcoma. Coatings 12:4, pages 524.
Crossref
Crossref
Yubo Shi, Yunyun Tian, Xiangran Sun, Yonglong Qiu & Yingchun Zhao. (2022) Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression. Frontiers in Oncology 12.
Crossref
Crossref
Junqing Li, Li Su, Xing Xiao, Feiran Wu, Guijuan Du, Xinjun Guo, Fanguo Kong, Jie Yao & Huimin Zhu. (2022) Development and Validation of Novel Prognostic Models for Immune-Related Genes in Osteosarcoma. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Erfan Mohammadi, Forough Alemi, Masomeh Maleki, Faezeh Malakoti, Nader Farsad-Akhtar & Bahman Yousefi. (2022) Quercetin and Methotrexate in Combination have Anticancer Activity in
Osteosarcoma Cells and Repress Oncogenic MicroRNA-223. Drug Research 72:04, pages 226-233.
Crossref
Crossref
De-Chen Yu, Xiang-Yi Chen, Hai-Yu Zhou, De-Quan Yu, Xiao-Lei Yu, Yi-Cun Hu, Rui-Hao Zhang, Xiao-Bo Zhang, Kun Zhang, Mao-Qiang Lin, Xi-Dan Gao & Tao-Wen Guo. (2022) TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells. Molecular Biology Reports 49:4, pages 3055-3064.
Crossref
Crossref
Bin Wang, Lifang Yan, Weihong Shi, Han Xie, Ruixiong Chen, Yanqing Shao & Weiguo Liang. (2022) CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis. International Journal of Clinical Oncology 27:4, pages 811-822.
Crossref
Crossref
Zhan Wang, Yuxin Song, Hui Zhang, Yang Yang, Suifeng Zhang & Wenji Wang. (2022) Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression. Aging 14:6, pages 2793-2804.
Crossref
Crossref
Qiang Wang, Yinghui Wu, Meng Lin, Gaigai Wang, Jinyan Liu, Min Xie, Bo Zheng, Cong Shen & Jun Shen. (2022) BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1. Cancer Cell International 22:1.
Crossref
Crossref
Dongming Lv, Shirong Ding, Li Zhong, Jian Tu, Hongbo Li, Hao Yao, Yutong Zou, Ziliang Zeng, Yan Liao, Xuesi Wan, Lili Wen & Xianbiao Xie. (2022) M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression. Oncogene 41:12, pages 1727-1741.
Crossref
Crossref
Kuo Jiang, Qianfeng Zhang, Yong Fan, Jia Li, Jitao Zhang, Wentao Wang, Jinzhu Fan, Yunshan Guo, Shichang Liu, Dingjun Hao, Yongxiang Wang, Lei Wang & Lequn Shan. (2022) MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma. Cell Death Discovery 8:1.
Crossref
Crossref
Peng Xu, Xiaoxi Li, Chao Tang, Tao Wang & Jiaming Xu. (2022) Deduction of CDC42EP3 suppress development and progression of osteosarcoma. Experimental Cell Research 412:1, pages 113018.
Crossref
Crossref
Chunmei Yang, Lulu Zhang, Huakun Huang, Xiaohui Yuan, Ping Zhang, Caihong Ye, Mengqi Wei, Yanran Huang, Xiaoji Luo & Jinyong Luo. (2022) Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways. Genes & Diseases 9:2, pages 466-478.
Crossref
Crossref
Jing Li, Chenguang Zhao, Yuhuan Li, Junxiang Wen, Shuang Wang, Difan Wang, Hui Dong, Dong Wang, Yonglin Zhao, Xiaohui Wang, Xijing He & Jie Qin. (2022) Osteosarcoma exocytosis of soluble LGALS3BP mediates macrophages toward a tumoricidal phenotype. Cancer Letters 528, pages 1-15.
Crossref
Crossref
Xiangran Sun, Di Zheng & Weichun Guo. (2022) Comprehensive Analysis of a Zinc Finger Protein Gene–Based Signature with Regard to Prognosis and Tumor Immune Microenvironment in Osteosarcoma. Frontiers in Genetics 13.
Crossref
Crossref
Pengfei Cui, Deqian Xin, Fu Li, Lin Deng & Yujie Gao. (2022) Butorphanol Suppresses the Proliferation and Migration of Osteosarcoma by Promoting the Expression of piRNA hsa_piR_006613. Frontiers in Oncology 12.
Crossref
Crossref
Yali Yu, Guixiang Dong, Zijun Li, Yan Zheng, Zhisong Shi & Guanghui Wang. (2022) circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis. International Journal of Oncology 60:4.
Crossref
Crossref
Liangliang Qu, Zhongqiu Li & Pinduan Liu. (2022) mir-204-5p Acts as a Tumor Suppressor by Targeting DNM2 in Osteosarcoma Cells. Journal of Healthcare Engineering 2022, pages 1-7.
Crossref
Crossref
Bo Yu, Lang Liu, Feng Cai, Yuanxiang Peng, Xiaofeng Tang, Duo Zeng, Teng Li, Feifei Zhang, Yiping Liang, Xuhui Yuan, Jiayu Li, Zhengzai Dai, Qi Liao & Xiao-Bin Lv. (2022) The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma. Cancer Cell International 22:1.
Crossref
Crossref
Emel Rothzerg, Abigail L Pfaff & Sulev Koks. (2022) Innovative approaches for treatment of osteosarcoma. Experimental Biology and Medicine 247:4, pages 310-316.
Crossref
Crossref
Zhenguo Liu, Junqiang Yin, Qian Zhou, Jiali Yang, Bo Zeng, Sai-Ching J. Yeung, Jingnan Shen & Chao Cheng. (2022) Survival after pulmonary metastasectomy for relapsed osteosarcoma. The Journal of Thoracic and Cardiovascular Surgery 163:2, pages 469-479.e8.
Crossref
Crossref
Peng Yin & Changgui Tong. (2022) LncRNA RGMB-AS1 up-regulates ANKRD1 Through Competitively Sponging miR-3614-5p to Promote OSA Cell Proliferation and Invasion. Archives of Medical Research 53:2, pages 131-137.
Crossref
Crossref
Junlei Zhang, Haijun Tang, Xiaohong Jiang, Nenggan Huang & Qingjun Wei. (2022) Hypoxia-Induced miR-378a-3p Inhibits Osteosarcoma Invasion and Epithelial-to-Mesenchymal Transition via BYSL Regulation. Frontiers in Genetics 12.
Crossref
Crossref
Jinpo Yang, Anran Zhang, Huan Luo & Chao Ma. (2022) Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. Scientific Reports 12:1.
Crossref
Crossref
Yuping Wang, Jin Chen, Yanran Huang, Shengdong Yang, Tao Tan, Nan Wang, Jun Zhang, Caihong Ye, Mengqi Wei, Jinyong Luo & Xiaoji Luo. (2022)
Schisandrin B suppresses osteosarcoma lung metastasis
in vivo
by inhibiting the activation of the Wnt/β‑catenin and PI3K/Akt signaling pathways
. Oncology Reports 47:3.
Crossref
Crossref
Xin Hu, Yang Wen, Lin-yun Tan, Jie Wang, Fan Tang, Yi-tian Wang, Chuan-xi Zheng, Yu-qi Zhang, Tao-jun Gong & Li Min. (2022) Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma. Frontiers in Oncology 11.
Crossref
Crossref
Xinying Zhou, Yang Yang, Yuejun Li, Guojun Liang, Dawei Kang, Bing Zhou & Qingchu Li. (2022) METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Taylor D. Ottesen, Blake N. Shultz, Alana M. Munger, Cosmas Sibindi, Alp Yurter, Arya G. Varthi & Jonathan N. Grauer. (2022) Characteristics, Management, and Outcomes of Patients With Osteosarcoma: An Analysis of Outcomes From the National Cancer Database. JAAOS: Global Research and Reviews 6:2.
Crossref
Crossref
Zong-Yuan Jiang, Ji-Bin Liu, Xiao-Feng Wang, Yu-Shui Ma & Da Fu. (2022) Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technology in Cancer Research & Treatment 21, pages 153303382211246.
Crossref
Crossref
Ana Santos, Cátia Domingues, Ivana Jarak, Francisco Veiga & Ana Figueiras. (2022) Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach. European Journal of Pharmaceutics and Biopharmaceutics 170, pages 91-111.
Crossref
Crossref
Yongkang Huang, Xinyun Zhai, Tengfei Ma, Mengzhen Zhang, Haobo Pan, William Weijia Lu, Xiaoli Zhao, Tianwei Sun, Yuqiao Li, Jie Shen, Chunhua Yan & Yaping Du. (2022) Rare earth-based materials for bone regeneration: Breakthroughs and advantages. Coordination Chemistry Reviews 450, pages 214236.
Crossref
Crossref
Anitha Radhakrishnan, Sreekanth Sreekumaran, Sudha Anjali, Rajalekshmi Resmi & Ramakrishna Perumal Saravana. 2022. Tissue Engineering. Tissue Engineering
469
492
.
Man Zhang, Jinti Lin, Jiakang Jin, Wei Yu, Yiying Qi & Huimin Tao. (2021) Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma Efficacy. Frontiers in Pharmacology 12.
Crossref
Crossref
Rende Ning, Guang Chen, Run Fang, Yanhui Zhang, Wenjuan Zhao & Feng Qian. (2021) Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cells. Biological Research 54:1.
Crossref
Crossref
Jun Wang, Mingzhi Gong, Zhenggang Xiong, Yangyang Zhao & Deguo Xing. (2021) Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Crossref
Pengxu Shi, Yueting Li & Qingsheng Guo. (2021) Circular RNA circPIP5K1A contributes to cancer stemness of osteosarcoma by miR-515-5p/YAP axis. Journal of Translational Medicine 19:1.
Crossref
Crossref
Qian Lu, Jun Lou, Ruyun Cai, Weidong Han & Hongming Pan. (2021) Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers. Cancer Cell International 21:1.
Crossref
Crossref
Displaying 200 of 414 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list